Leadership Overview
Cochlear has 5 executives leading key functions including strategy, information technology, finance, regional operations, and market expansion.
Driven by innovation in hearing solutions, Cochlear designs, manufactures, and supplies advanced cochlear implants and bone conduction systems, impacting lives globally through cutting-edge medical technology.
Driven by innovation in hearing solutions, Cochlear designs, manufactures, and supplies advanced cochlear implants and bone conduction systems, impacting lives globally through cutting-edge medical technology.
Leadership Roles at Cochlear
Dig Howitt - Chief Executive Officer & President
Dig Howitt, the Chief Executive Officer & President at Cochlear, directs the company's overall strategic vision and operational execution. Overseeing global business functions, Howitt ensures alignment with Cochlear's mission to improve hearing through advanced medical devices. This leadership role involves driving innovation in implantable hearing solutions, including the Nucleus cochlear implant and Baha bone conduction implant. By fostering cross-functional collaboration, Dig Howitt guides the company's expansion into new markets and enhances its existing presence in Australia and worldwide. The Chief Executive Officer & President's focus remains on sustainable growth and delivering superior patient outcomes through technological advancement and market leadership.
Neville Mitchell - Chief Financial Officer
Neville Mitchell, the Chief Financial Officer at Cochlear, directs the company's financial strategy and fiscal operations. Overseeing all aspects of financial planning, reporting, and investment, Mitchell ensures the economic health and sustainability of Cochlear's global enterprise. This leadership position involves managing capital allocation, optimizing financial performance, and driving shareholder value. By providing critical financial insights, Neville Mitchell supports strategic decision-making across the organization, enabling the continued design, manufacturing, and distribution of advanced medical devices like the Nucleus cochlear implant. The Chief Financial Officer's expertise is vital for Cochlear's expansion and its commitment to delivering life-changing hearing solutions worldwide.
Christopher Bertrand - President (Latin America) & Head of Emerging Market Council
Christopher Bertrand, the President (Latin America) & Head of Emerging Market Council at Cochlear, spearheads growth initiatives across key developing regions. Overseeing market penetration and strategic partnerships, Bertrand drives the adoption of Cochlear's implantable hearing solutions in Latin America and other emerging markets. This role involves tailoring market entry strategies and ensuring localized support for patients and healthcare professionals. By leading the Emerging Market Council, Christopher Bertrand fosters collaboration and knowledge sharing to accelerate Cochlear's global reach. The President (Latin America) & Head of Emerging Market Council's efforts are crucial for expanding access to life-changing technologies and reinforcing Cochlear's commitment to diverse patient populations.
Stuart Sayers - President, Asia Pacific & Latin America
Stuart Sayers, the President, Asia Pacific & Latin America at Cochlear, directs the company's commercial operations and strategic development across these vital regions. Overseeing sales, marketing, and distribution networks, Sayers ensures the effective delivery of Cochlear's advanced hearing implants to a broad patient base. This leadership role involves cultivating strong relationships with healthcare providers and key stakeholders to expand market access for the Nucleus cochlear implant and Baha bone conduction implant. By driving regional growth strategies, Stuart Sayers supports Cochlear's mission to improve hearing outcomes globally. The President, Asia Pacific & Latin America's focus is on enhancing patient access and solidifying Cochlear's market leadership in diverse geographical landscapes.
Karen O'Driscoll - Chief Information Officer
Karen O'Driscoll, the Chief Information Officer at Cochlear, architects the company's global technology infrastructure and digital strategy. Overseeing all information systems, O'Driscoll ensures robust cybersecurity measures and efficient data management to support Cochlear's medical device operations. This critical role involves implementing advanced IT solutions that enhance product development, manufacturing processes, and customer support worldwide. By driving digital transformation initiatives, Karen O'Driscoll enables seamless integration of new technologies across the organization, supporting the design, manufacturing, and supply of the Nucleus cochlear implant and other vital hearing solutions. The Chief Information Officer's leadership ensures technological capabilities directly support Cochlear's mission to improve lives.
Explore Leadership Teams in Manufacturing
Terumo is a global medical device company originating from Japan. The company pursues reliable quality and advanced technology to contribute to healthcare across countries and regions worldwide. It focuses on reducing patients’ difficulties both mentally and physically while delivering solutions that help address challenges in medical settings. Terumo remains committed to working alongside healthcare professionals to make meaningful contributions to society, now and into the future.
Company Leadership SU
PL
YK
KT
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Company Leadership
ME
Masimo Corporation is a global medical technology company founded in 1989 by engineer Joe Kiani and headquartered in Irvine, California. The company develops, manufactures, and markets innovative noninvasive patient monitoring technologies, medical devices, sensors, hospital automation and connectivity solutions, and telehealth platforms used in hospital and home healthcare settings worldwide. Masimo is best known for its proprietary Signal Extraction Technology pulse oximetry, introduced in 1995, which revolutionized pulse oximetry by enabling accurate measurement of arterial blood oxygen saturation and pulse rate even during patient motion and low perfusion conditions that cause conventional pulse oximeters to fail or provide inaccurate readings.
Company Leadership
MA
Headquartered in Marlborough, Massachusetts, and formerly part of GE Healthcare Life Sciences, Cytiva is a global provider of medical application technologies and services that advance and accelerate the development of therapeutics.
Company Leadership SO
CR
MP
AL
Frequently Asked Questions Regarding Cochlear Top Executives and Leadership Team
